Found: 9
Select item for more details and to access through your institution.
Impaired T-bet-pSTAT1α and perforin-mediated immune responses in the tumoral region of lung adenocarcinoma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Contribution of serum lipids and cholesterol cellular metabolism in lung cancer development and progression.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-31575-y
- By:
- Publication type:
- Article
IL-9 Producing Tumor-Infiltrating Lymphocytes and Treg Subsets Drive Immune Escape of Tumor Cells in Non-Small Cell Lung Cancer.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.859738
- By:
- Publication type:
- Article
Pleural Resident Macrophages and Pleural IRA B Cells Promote Efficient Immunity Against Pneumonia by Inducing Early Pleural Space Inflammation.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.821480
- By:
- Publication type:
- Article
Increased expression of the immunosuppressive interleukin-35 in patients with non-small cell lung cancer.
- Published in:
- British Journal of Cancer, 2019, v. 120, n. 9, p. 903, doi. 10.1038/s41416-019-0444-3
- By:
- Publication type:
- Article
Increased expression of the immunosuppressive interleukin-35 in patients with non-small cell lung cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Increased expression of the Th17-IL-6R/pSTAT3/BATF/RorγT-axis in the tumoural region of adenocarcinoma as compared to squamous cell carcinoma of the lung.
- Published in:
- Scientific Reports, 2014, p. 1, doi. 10.1038/srep07396
- By:
- Publication type:
- Article
Glucose-Restricted Diet Regulates the Tumor Immune Microenvironment and Prevents Tumor Growth in Lung Adenocarcinoma.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.873293
- By:
- Publication type:
- Article
Short-chain fatty acids induced lung tumor cell death and increased peripheral blood CD4+ T cells in NSCLC and control patients ex vivo.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1328263
- By:
- Publication type:
- Article